During the past decade, Kaiser Permanente Downtown Commons conducted 73 clinical trials. In the 10-year time frame, 73 clinical trials started and 7 clinical trials were completed, i.e. on average, 9.6% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 7 clinical trials were completed. i.e. 21.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente Downtown Commons" #1 sponsor was "National Cancer Institute (NCI)" with 36 trials, followed by "SWOG Cancer Research Network" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored and "NRG Oncology" with 7 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Downtown Commons" #1 collaborator was "National Cancer Institute (NCI)" with 43 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Downtown Commons" are "Stage IV Lung Cancer AJCC v8" (8 trials), "Stage IIIA Breast Cancer" (6 trials), "Stage IVA Lung Cancer AJCC v8" (6 trials), "Stage IVB Lung Cancer AJCC v8" (6 trials) and "Invasive Breast Carcinoma" (5 trials). Many other conditions were trialed in "Kaiser Permanente Downtown Commons" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente Downtown Commons" are "Drug" (57 trials), "Other" (48 trials), "Procedure" (33 trials), "Biological" (32 trials) and "Radiation" (12 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (25 trials), "Questionnaire Administration" (20 trials), "Computed Tomography" (18 trials), "Nivolumab" (18 trials) and "Biospecimen Collection" (16 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente Downtown Commons" are 66 trials for "All" genders, 10 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente Downtown Commons". undefined are not yet recruiting, 30 are recruiting, 40 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Kaiser Permanente Downtown Commons, 4 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente Downtown Commons, 1 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 49 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".